O. Brawley, L. Cornelius, L. Edwards, V. Gamble, B. Green, C. Inturrisi, et al., “NIH Conference Annals of Internal Medicine National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease,” Annals of Internal Medicine, Vol. 148, No. 12, 2008, pp. 932-938. doi:10.7326/0003-4819-148-12-200806170-00220

has been cited by the following article:

• TITLE: Cutaneous Manifestations of Sickle Cell Disease

  AUTHORS: Heather Jones, Morey Blinder, Milan Anadkat

  KEYWORDS: Sickle Cell Disease; Leg Ulcers; Pseudoxanthoma Elasticum; Nitric Oxide Deficiency; Hydroxyurea

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.3 No.3, September 16, 2013

  ABSTRACT: Sickle cell disease is an inherited erythrocyte disorder affecting multiple organ systems. As individuals are living well into middle age due to advances in diagnosis and treatment, further disease-related complications are being recognized. This article reviews the cutaneous manifestations of sickle cell disease including leg ulcers and acquired pseudoxanthoma elasticum.